9-Piperazino ofloxacin, (S)-

Basic Information

View in Editor

CAS Number

178912-62-4

Molecular Formula

C18H20FN3O4

Molecular Weight

361.37 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Fine Chemicals Specialty Chemicals UV Stabilizers

Agricultural Chemicals Pesticides Herbicides

Basic Physical Properties

SMILES

View in Editor

CC1COC2=C3N1C=C(C(=O)C3=CC(=C2F)N4CCN(CC4)C)C(=O)O

InChI

InChI=1S/C18H20FN3O4/c1-10-9-26-17-14(19)13(21-5-3-20(2)4-6-21)7-11-15(17)22(10)8-12(16(11)23)18(24)25/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1

InChIKey

FHAKLRRIGREDDW-JTQLQIEISA-N

LogP

1.5439999999999994

Topological Polar Surface Area

75.01 Å²

Hydrogen Bond Donor/Acceptor

1 / 7

Complexity

634

Synonyms & References

English

9-Piperazino Levofloxacin
9-Piperazine Levofloxacin Impurity 9
9-Piperazino Levoflo
9-PIPERAZINO LEVOFLOXACIN IMPURITY
(S)-10-fluoro-3-methyl-9-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
Levofloxacin Impurity M
Levofloxacin 9-Piperazinyl Isomer
9-Piperazine Levofloxacin IMpurity
F19368
(S)-10-Fluoro-3-methyl-9-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7h-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(S)-10-Fluoro-3-methyl-9-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7h-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylicacid
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 10-fluoro-2,3-dihydro-3-methyl-9-(4-methyl-1-piperazinyl)-7-oxo-, (S)-
(3S)-10-Fluoro-3-methyl-9-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
Q27254235
9-Piperazino levofloxacin
UNII-27UD9BY435
27UD9BY435
(S)-9-piperazino ofloxacin
9-Piperazino ofloxacin, (S)-
9-Piperazine Levofloxacin Impurity
(2S)-6-fluoro-2-methyl-7-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
10-Fluoro-9-(4-methylpiperazin-1-yl)-ofloxacin, (S)-
LEVOFLOXACIN HEMIHYDRATE IMPURITY I [EP IMPURITY]
178912-62-4
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 10-fluoro-2,3-dihydro-3-methyl-9-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI); (3S)-10-Fluoro-3-methyl-9-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic Acid
DTXSID20170613

FAQ

What regulatory guidelines apply to 9-Piperazino ofloxacin, (S)- (CAS: 178912-62-4)?

9-Piperazino ofloxacin, (S)- (CAS: 178912-62-4) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and FDA/EPA requirements in the United States. Specifically, it must be classified and labeled according to its toxicity, flammability, and environmental hazards. Manufacturers and importers must ensure compliance with these regulations for safe handling, packaging, and transportation.

Are there alternatives to 9-Piperazino ofloxacin, (S)- (CAS: 178912-62-4) in synthesis?

While 9-Piperazino ofloxacin, (S)- (CAS: 178912-62-4) is a specific compound, its synthesis can potentially be optimized using alternative reagents such as different piperazine derivatives or isomers. Common alternatives include the use of (R)-9-piperazino ofloxacin or other fluoroquinolone derivatives. These alternatives can offer similar antibacterial properties but with potentially different side effects or synthetic challenges.

What is the market or research trend for 9-Piperazino ofloxacin, (S)- (CAS: 178912-62-4)?

The market for 9-Piperazino ofloxacin, (S)- (CAS: 178912-62-4) is closely associated with the broader fluoroquinolone market. Research trends are focusing on the development of more potent and less toxic derivatives, as well as the exploration of its potential in treating resistant bacterial infections. Market demand is driven by increasing antibiotic resistance and the need for effective antibacterial agents. Additionally, there is ongoing research into its pharmacokinetic and pharmacodynamic properties.

How should waste containing 9-Piperazino ofloxacin, (S)- (CAS: 178912-62-4) be handled?

Waste containing 9-Piperazino ofloxacin, (S)- (CAS: 178912-62-4) should be collected in leak-proof containers and stored in a secure area with appropriate labeling. It should be disposed of through a licensed hazardous waste disposal service, following local and national regulations. Incineration is a common method for disposing of such waste, but it must be conducted in an appropriately equipped facility to prevent environmental contamination. Proper environmental precautions include monitoring of air and water quality post-disposal to ensure compliance with regulatory standards.